Wells Fargo’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $503K | Buy |
38,384
+3,226
| +9% | +$42.3K | ﹤0.01% | 3790 |
|
|
2025
Q1 | $773K | Buy |
35,158
+1,240
| +4% | +$27.3K | ﹤0.01% | 3407 |
|
|
2024
Q4 | $906K | Buy |
33,918
+11,561
| +52% | +$309K | ﹤0.01% | 3334 |
|
|
2024
Q3 | $597K | Sell |
22,357
-884
| -4% | -$23.6K | ﹤0.01% | 3515 |
|
|
2024
Q2 | $419K | Buy |
23,241
+2,810
| +14% | +$50.6K | ﹤0.01% | 3680 |
|
|
2024
Q1 | $373K | Buy |
20,431
+7,255
| +55% | +$132K | ﹤0.01% | 3727 |
|
|
2023
Q4 | $144K | Buy |
13,176
+2,602
| +25% | +$28.5K | ﹤0.01% | 4278 |
|
|
2023
Q3 | $60.6K | Sell |
10,574
-5,710
| -35% | -$32.7K | ﹤0.01% | 4736 |
|
|
2023
Q2 | $126K | Buy |
16,284
+9,527
| +141% | +$73.8K | ﹤0.01% | 4627 |
|
|
2023
Q1 | $45.1K | Buy |
+6,757
| New | +$45.1K | ﹤0.01% | 4921 |
|
|
2022
Q4 | – | Sell |
-59
| Closed | -$1K | – | 7186 |
|
|
2022
Q3 | $1K | Sell |
59
-197
| -77% | -$3.34K | ﹤0.01% | 5995 |
|
|
2022
Q2 | $2K | Sell |
256
-3,676
| -93% | -$28.7K | ﹤0.01% | 6012 |
|
|
2022
Q1 | $38K | Sell |
3,932
-13,920
| -78% | -$135K | ﹤0.01% | 5444 |
|
|
2021
Q4 | $273K | Buy |
+17,852
| New | +$273K | ﹤0.01% | 4742 |
|